Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
BioNTech Analyst Ratings and Price Targets | NASDAQ:BNTX | Benzinga
BioNTech SE has a consensus price target of $151.36 based on the ratings of 22 analysts. The high is $224 issued by SVB Leerink on July 29, 2022. The low is $111 issued by Morgan Stanley on November 8, 2023. The 3 most-recent analyst ratings were released by Citigroup, Morgan Stanley, and Canaccord Genuity on March 13, 2025, March 11, 2025, and March 11, 2025, respectively. With an average price target of $151.81 between Citigroup, Morgan Stanley, and Canaccord Genuity, there's an implied 56.38% upside for BioNTech SE from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Morgan Stanley
Canaccord Genuity
BMO Capital
Truist Securities
1calculated from analyst ratings
Analyst Ratings for BioNTech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 49.36% | Citigroup | Geoff Meacham63% | → $145 | Initiates | → Buy | Get Alert |
| 03/11/2025 | Buy Now | 43.18% | Morgan Stanley | Terence Flynn66% | $145 → $139 | Maintains | Overweight | Get Alert |
| 03/11/2025 | Buy Now | 76.6% | Canaccord Genuity | John Newman45% | $171.44 → $171.44 | Maintains | Buy | Get Alert |
| 03/11/2025 | Buy Now | 47.3% | BMO Capital | Etzer Darout49% | $130 → $143 | Maintains | Outperform | Get Alert |
| 01/10/2025 | Buy Now | 77.17% | Truist Securities | Asthika Goonewardene41% | → $172 | Initiates | → Buy | Get Alert |
| 12/11/2024 | Buy Now | 75.11% | Wells Fargo | Mohit Bansal73% | → $170 | Initiates | → Overweight | Get Alert |
| 11/27/2024 | Buy Now | 76.6% | Canaccord Genuity | William Maughan71% | $171 → $171.44 | Maintains | Buy | Get Alert |
| 11/26/2024 | Buy Now | 25.67% | JP Morgan | Jessica Fye68% | $124 → $122 | Maintains | Neutral | Get Alert |
| 11/19/2024 | Buy Now | 28.76% | Evercore ISI Group | Cory Kasimov69% | $110 → $125 | Upgrade | In-Line → Outperform | Get Alert |
| 11/18/2024 | Buy Now | 76.14% | Canaccord Genuity | John Newman45% | $171 → $171 | Maintains | Buy | Get Alert |
| 11/18/2024 | Buy Now | 54.51% | HC Wainwright & Co. | Robert Burns42% | $150 → $150 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | 76.14% | Canaccord Genuity | John Newman45% | $171 → $171 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 41.12% | Goldman Sachs | Chris Shibutani54% | $90 → $137 | Upgrade | Neutral → Buy | Get Alert |
| 11/06/2024 | Buy Now | 25.67% | TD Cowen | Yaron Werber35% | $132 → $122 | Maintains | Hold | Get Alert |
| 11/05/2024 | Buy Now | 25.67% | TD Cowen | Yaron Werber35% | $132 → $122 | Maintains | Hold | Get Alert |
| 11/04/2024 | Buy Now | 27.73% | JP Morgan | Jessica Fye68% | $125 → $124 | Maintains | Neutral | Get Alert |
| 10/07/2024 | Buy Now | 40.09% | HSBC | Yifeng Liu38% | $97 → $136 | Maintains | Buy | Get Alert |
| 10/07/2024 | Buy Now | 54.51% | HC Wainwright & Co. | Robert Burns42% | $113 → $150 | Maintains | Buy | Get Alert |
| 09/24/2024 | Buy Now | 49.36% | Morgan Stanley | Terence Flynn66% | $93 → $145 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/19/2024 | Buy Now | 54.51% | Deutsche Bank | Emmanuel Papadakis47% | $95 → $150 | Maintains | Buy | Get Alert |
| 09/18/2024 | Buy Now | 34.94% | UBS | Eliana Merle46% | $97 → $131 | Maintains | Neutral | Get Alert |
| 09/17/2024 | Buy Now | 54.51% | Jefferies | Akash Tewari45% | $96 → $150 | Upgrade | Hold → Buy | Get Alert |
| 09/16/2024 | Buy Now | 28.76% | JP Morgan | Jessica Fye68% | $91 → $125 | Upgrade | Underweight → Neutral | Get Alert |
| 09/16/2024 | Buy Now | 54.51% | B of A Securities | Tazeen Ahmad56% | $125 → $150 | Maintains | Buy | Get Alert |
| 09/16/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2024 | Buy Now | -1.11% | Jefferies | Akash Tewari45% | $90 → $96 | Maintains | Hold | Get Alert |
| 08/27/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 08/19/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | -6.26% | JP Morgan | Jessica Fye68% | $94 → $91 | Maintains | Underweight | Get Alert |
| 08/07/2024 | Buy Now | -2.14% | Deutsche Bank | Emmanuel Papadakis47% | $95 → $95 | Upgrade | Hold → Buy | Get Alert |
| 08/06/2024 | Buy Now | -12.44% | TD Cowen | Yaron Werber35% | $98 → $85 | Maintains | Hold | Get Alert |
| 08/01/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2024 | Buy Now | -3.17% | JP Morgan | Jessica Fye68% | $90 → $94 | Maintains | Underweight | Get Alert |
| 06/10/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/28/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 3.01% | Evercore ISI Group | Cory Kasimov69% | → $100 | Initiates | → In-Line | Get Alert |
| 05/08/2024 | Buy Now | 16.4% | HC Wainwright & Co. | Robert Burns42% | $107 → $113 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 0.95% | TD Cowen | Yaron Werber35% | $95 → $98 | Maintains | Hold | Get Alert |
| 05/07/2024 | Buy Now | 25.67% | BMO Capital | Etzer Darout49% | $123 → $122 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 10.22% | HC Wainwright & Co. | Robert Burns42% | $107 → $107 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | 4.04% | UBS | Eliana Merle46% | $110 → $101 | Maintains | Neutral | Get Alert |
| 03/22/2024 | Buy Now | -7.29% | JP Morgan | Jessica Fye68% | $99 → $90 | Maintains | Underweight | Get Alert |
| 03/21/2024 | Buy Now | 76.14% | Canaccord Genuity | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | Buy Now | 26.7% | BMO Capital | Etzer Darout49% | $127 → $123 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | 3.01% | Goldman Sachs | Chris Shibutani54% | $113 → $100 | Maintains | Neutral | Get Alert |
| 02/23/2024 | Buy Now | 76.14% | Canaccord Genuity | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 02/23/2024 | Buy Now | 30.82% | BMO Capital | Etzer Darout49% | → $127 | Initiates | → Outperform | Get Alert |
| 02/21/2024 | Buy Now | 76.14% | Canaccord Genuity | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2024 | Buy Now | 76.14% | Canaccord Genuity | John Newman45% | $168 → $171 | Maintains | Buy | Get Alert |
| 01/23/2024 | Buy Now | 10.22% | HC Wainwright & Co. | Robert Burns42% | $133 → $107 | Maintains | Buy | Get Alert |
| 12/01/2023 | Buy Now | 1.98% | JP Morgan | Jessica Fye68% | $106 → $99 | Downgrade | Neutral → Underweight | Get Alert |
| 11/27/2023 | Buy Now | 37% | HC Wainwright & Co. | Robert Burns42% | → $133 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | Buy Now | 37% | HC Wainwright & Co. | Robert Burns42% | $180 → $133 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 14.34% | Morgan Stanley | Matthew Korn46% | $110 → $111 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 13.31% | Morgan Stanley | Matthew Korn46% | $116 → $110 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | 14.34% | HSBC | Yifeng Liu38% | $124 → $111 | Downgrade | Buy → Hold | Get Alert |
| 08/28/2023 | Buy Now | 85.41% | HC Wainwright & Co. | Robert Burns42% | → $180 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | Buy Now | 85.41% | HC Wainwright & Co. | Robert Burns42% | $181 → $180 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | 19.49% | Morgan Stanley | Matthew Korn46% | $119 → $116 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | Buy Now | 22.58% | Morgan Stanley | Matthew Korn46% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | 22.58% | Morgan Stanley | Matthew Korn46% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | Buy Now | 22.58% | Morgan Stanley | Matthew Korn46% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | Buy Now | 22.58% | Morgan Stanley | Matthew Korn46% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/14/2023 | Buy Now | 27.73% | HSBC | Rajesh Kumar65% | → $124 | Initiates | → Buy | Get Alert |
| 07/11/2023 | Buy Now | 22.58% | Morgan Stanley | Matthew Korn46% | $124 → $119 | Maintains | Equal-Weight | Get Alert |
| 06/26/2023 | Buy Now | 27.73% | Morgan Stanley | Matthew Korn46% | $124 → $124 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/20/2023 | Buy Now | 27.73% | Morgan Stanley | Matthew Korn46% | → $124 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/16/2023 | Buy Now | 109.11% | Canaccord Genuity | John Newman45% | $203 → $203 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | Buy Now | 27.73% | Morgan Stanley | Matthew Korn46% | → $124 | Reiterates | → Equal-Weight | Get Alert |
| 06/09/2023 | Buy Now | 86.44% | HC Wainwright & Co. | Robert Burns42% | → $181 | Reiterates | → Buy | Get Alert |
| 06/01/2023 | Buy Now | 86.44% | HC Wainwright & Co. | Robert Burns42% | $198 → $181 | Maintains | Buy | Get Alert |
| 05/23/2023 | Buy Now | 103.96% | HC Wainwright & Co. | Robert Burns42% | $210 → $198 | Maintains | Buy | Get Alert |
| 05/18/2023 | Buy Now | 23.61% | Deutsche Bank | Emmanuel Papadakis47% | $135 → $120 | Maintains | Hold | Get Alert |
| 05/17/2023 | Buy Now | 75.11% | Redburn Partners | Simon Baker26% | $165 → $170 | Upgrade | Neutral → Buy | Get Alert |
| 05/09/2023 | Buy Now | 27.73% | Morgan Stanley | Matthew Korn46% | $150 → $124 | Maintains | Equal-Weight | Get Alert |
| 04/24/2023 | Buy Now | 39.06% | Deutsche Bank | Emmanuel Papadakis47% | $160 → $135 | Maintains | Hold | Get Alert |
| 04/10/2023 | Buy Now | 31.85% | JP Morgan | Jessica Fye68% | $142 → $128 | Maintains | Neutral | Get Alert |
| 03/31/2023 | Buy Now | 57.6% | UBS | Eliana Merle46% | $168 → $153 | Maintains | Neutral | Get Alert |
| 03/30/2023 | Buy Now | 116.32% | HC Wainwright & Co. | Robert Burns42% | → $210 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | Buy Now | 109.11% | Canaccord Genuity | William Maughan71% | $191 → $203 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | 33.91% | TD Cowen | Yaron Werber35% | $145 → $130 | Maintains | Market Perform | Get Alert |
| 03/28/2023 | Buy Now | 99.84% | B of A Securities | Tazeen Ahmad56% | $239 → $194 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | 54.51% | Morgan Stanley | Matthew Korn46% | $216 → $150 | Maintains | Equal-Weight | Get Alert |
| 03/28/2023 | Buy Now | 44.21% | Goldman Sachs | Chris Shibutani54% | $156 → $140 | Maintains | Neutral | Get Alert |
| 03/23/2023 | Buy Now | 116.32% | HC Wainwright & Co. | Robert Burns42% | $272 → $210 | Maintains | Buy | Get Alert |
| 02/08/2023 | Buy Now | 46.27% | JP Morgan | Jessica Fye68% | $148 → $142 | Maintains | Neutral | Get Alert |
| 01/31/2023 | Buy Now | 60.69% | Goldman Sachs | Chris Shibutani54% | $177 → $156 | Maintains | Neutral | Get Alert |
| 01/24/2023 | Buy Now | 122.5% | Morgan Stanley | Matthew Harrison60% | $203 → $216 | Maintains | Equal-Weight | Get Alert |
| 12/15/2022 | Buy Now | 146.19% | B of A Securities | Tazeen Ahmad56% | → $239 | Upgrade | Neutral → Buy | Get Alert |
| 11/11/2022 | Buy Now | 64.81% | Deutsche Bank | Emmanuel Papadakis47% | $180 → $160 | Maintains | Hold | Get Alert |
| 11/08/2022 | Buy Now | 109.11% | Morgan Stanley | Matthew Harrison60% | $194 → $203 | Maintains | Equal-Weight | Get Alert |
| 11/08/2022 | Buy Now | 82.32% | Goldman Sachs | Chris Shibutani54% | $200 → $177 | Maintains | Neutral | Get Alert |
| 10/24/2022 | Buy Now | 35.97% | JP Morgan | Jessica Fye68% | $183 → $132 | Maintains | Neutral | Get Alert |
| 08/10/2022 | Buy Now | 180.18% | HC Wainwright & Co. | Robert Burns42% | $283 → $272 | Maintains | Buy | Get Alert |
| 07/29/2022 | Buy Now | 130.74% | SVB Leerink | Daina Graybosch42% | $223 → $224 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for BioNTech (BNTX) stock?
The latest price target for BioNTech (NASDAQ:BNTX) was reported by Citigroup on March 13, 2025. The analyst firm set a price target for $145.00 expecting BNTX to rise to within 12 months (a possible 49.36% upside). 46 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioNTech (BNTX)?
The latest analyst rating for BioNTech (NASDAQ:BNTX) was provided by Citigroup, and BioNTech initiated their buy rating.
When was the last upgrade for BioNTech (BNTX)?
The last upgrade for BioNTech SE happened on November 19, 2024 when Evercore ISI Group raised their price target to $125. Evercore ISI Group previously had an in-line for BioNTech SE.
When was the last downgrade for BioNTech (BNTX)?
The last downgrade for BioNTech SE happened on December 1, 2023 when JP Morgan changed their price target from $106 to $99 for BioNTech SE.
When is the next analyst rating going to be posted or updated for BioNTech (BNTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioNTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioNTech was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating BioNTech (BNTX) correct?
While ratings are subjective and will change, the latest BioNTech (BNTX) rating was a initiated with a price target of $0.00 to $145.00. The current price BioNTech (BNTX) is trading at is $97.08, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.